Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.355 USD | -3.30% | -5.71% | -15.47% |
12:12am | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
09/05 | Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Reports Q1 Revenue $13.8M, vs. Street Est of $12.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.47% | 2.06B | |
+3.32% | 108B | |
+11.10% | 104B | |
+1.28% | 22.33B | |
-12.78% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.60% | 17.64B | |
+4.27% | 14.05B | |
+34.94% | 12.51B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals Insider Sold Shares Worth $517,508, According to a Recent SEC Filing